Tag: VR315

Posted on

Sandoz Negotiates Expanded RoW Rights to Vectura’s Asthma/COPD Drug VR315 – Genetic Engineering News


Stockopedia

Sandoz Negotiates Expanded RoW Rights to Vectura's Asthma/COPD Drug VR315
Genetic Engineering News
The Novartis generics business, Sandoz, negotiated expanded, rest-of-world (excluding the US) rights to Vectura's VR315 candidate combination therapy for asthma/COPD. Sandoz already holds European rights to the dry powder inhaler product. …
Vectura Extends Novartis Deal For VR315 Lung DrugFox Business
VECTURA GROUP PLC : VR315 RoW License Agreement4-traders (press release)
Vectura signs up Sandoz for asthma drug in RoW; good results for ALK Abello …The Pharma Letter
Stockopedia
all 9 news articles »

View full post on asthma – Google News

Posted on

Vectura Extends Novartis Deal For VR315 Lung Drug – Fox Business


Stockopedia

Vectura Extends Novartis Deal For VR315 Lung Drug
Fox Business
VX) for its generic asthma medicine VR315, covering markets outside Europe and North America. The deal follows hot on the heals of a US licensing agreement for the drug with an unnamed company earlier this week, and means Vectura has now licensed the …
VECTURA GROUP PLC : VR315 RoW License Agreement4-traders (press release)
Vectura signs up Sandoz for asthma drug in RoW; good results for ALK Abello …The Pharma Letter
Vectura agrees new licensing deal with Sandoz for asthma treatmentStockopedia

all 8 news articles »

View full post on asthma – Google News

Posted on

Vectura Signs Up US Partner For VR315 Lung Drug – NASDAQ

Vectura Signs Up US Partner For VR315 Lung Drug
NASDAQ
LN) said Wednesday it has signed a US licensing deal for its generic asthma medicine VR315 with an unnamed "leading international pharmaceutical company." VR315, a drug that industry observers say is a copycat version of GlaxoSmithKline PLC's (GSK. …
Vectura signs US license agreement for VR315 productStock Market Wire
Vectura gets new US partner for copy of lung drugReuters
US deal for Vectura; takeover bid for AMAGThe Pharma Letter
Pharmaceutical Business Review
all 12 news articles »

View full post on asthma – Google News